GREM1 and intestinal disorder: Taken together, those studies suggest that reducing GREM1 mRNA (and thus protein) expression or inhibiting GREM1 function may be a novel therapeutic strategy in intestinal disorders characterised by dysregulated Wnt–BMP signalling or aberrant gremlin 1 expression.